Advanced Biomedical Technologies (OTCMKTS:ABMT) & Solana (NASDAQ:HSDT) Head to Head Analysis

Advanced Biomedical Technologies (OTCMKTS:ABMT) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Volatility & Risk

Advanced Biomedical Technologies has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Comparatively, Solana has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.

Profitability

This table compares Advanced Biomedical Technologies and Solana’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Advanced Biomedical Technologies	N/A	N/A	N/A
Solana	-679.54%	-104.96%	-20.67%

Valuation & Earnings

This table compares Advanced Biomedical Technologies and Solana”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomedical Technologies	N/A	N/A	N/A	N/A	N/A
Solana	$6.02 million	19.33	-$40.89 million	($490.68)	0.00

Advanced Biomedical Technologies has higher earnings, but lower revenue than Solana.

Analyst Recommendations

This is a summary of current ratings and price targets for Advanced Biomedical Technologies and Solana, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomedical Technologies	0	0	0	0	0.00
Solana	1	0	1	0	2.00

Solana has a consensus price target of $4.00, indicating a potential upside of 88.68%. Given Solana’s stronger consensus rating and higher probable upside, analysts clearly believe Solana is more favorable than Advanced Biomedical Technologies.

Insider and Institutional Ownership

18.6% of Solana shares are owned by institutional investors. 34.1% of Advanced Biomedical Technologies shares are owned by insiders. Comparatively, 17.2% of Solana shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

About Advanced Biomedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

About Solana

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.